Nikhil Lalwani
PRESIDENT & CEO at ANI Pharmaceuticals Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: ANI Pharmaceuticals Inc., 3 years.
ANI Pharmaceuticals Inc.
Director · PRESIDENT & CEO
Chief executive roles
ANI Pharmaceuticals Inc.
· PRESIDENT & CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 23, 2025 | ANI Pharmaceuticals Inc. | Shares withheld for tax | −17,455 | $64.26 | $1,121,658 |
| Mar 7, 2025 | ANI Pharmaceuticals Inc. | Shares withheld for tax | −17,060 | $60.62 | $1,034,177 |
| Feb 28, 2025 | ANI Pharmaceuticals Inc. | Shares withheld for tax | −12,216 | $61.89 | $756,048 |
| Feb 14, 2025 | ANI Pharmaceuticals Inc. | Shares withheld for tax | −7,799 | $58.92 | $459,517 |
| Feb 12, 2025 | ANI Pharmaceuticals Inc. | Grant or award | +91,399 | — | — |
| Feb 12, 2025 | ANI Pharmaceuticals Inc. | Grant or award | +60,932 | — | — |
| Nov 26, 2024 | ANI Pharmaceuticals Inc. | Option exercise | +30,000 | $29.00 | $870,000 |
| Nov 26, 2024 | ANI Pharmaceuticals Inc. | Open-market sale | −30,000 | $57.95 | $1,738,500 |
| Nov 26, 2024 | ANI Pharmaceuticals Inc. | Open-market sale | −3,481 | $58.30 | $202,942 |
| Sep 8, 2024 | ANI Pharmaceuticals Inc. | Shares withheld for tax | −3,646 | $60.51 | $220,619 |
| May 14, 2024 | ANI Pharmaceuticals Inc. | Open-market sale | −16,669 | $66.10 | $1,101,821 |
| Mar 23, 2024 | ANI Pharmaceuticals Inc. | Shares withheld for tax | −17,455 | $69.58 | $1,214,519 |
| Mar 8, 2024 | ANI Pharmaceuticals Inc. | Open-market sale | −16,292 | $67.13 | $1,093,682 |
| Mar 7, 2024 | ANI Pharmaceuticals Inc. | Shares withheld for tax | −17,060 | $66.71 | $1,138,073 |
| Mar 6, 2024 | ANI Pharmaceuticals Inc. | Open-market sale | −28,965 | $65.52 | $1,897,787 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.